No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CSL240517C400000
- 7.00
- 0.000.00%
15min DelayTrading May 8 09:37 ET
0.00High0.00Low
0.00Open7.00Pre Close0 Volume259 Open Interest400.00Strike Price0.00Turnover0.00%IV0.28%PremiumMay 17, 2024Expiry Date11.66Intrinsic Value100Multiplier8DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma32.16Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Does Carlisle Companies (NYSE:CSL) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might
Carlisle Companies(CSL.US) Officer Sells US$435.26K in Common Stock
$Carlisle Companies(CSL.US)$ Officer ALDRICH STEPHEN sold 1,095 shares of common stock on May 3, 2024 at an average price of $397.5 for a total value of $435.26K.Source: Announcement What is statement
Carlisle Companies(CSL.US) Officer Sells US$826.17K in Common Stock
$Carlisle Companies(CSL.US)$ Officer SMITH DAVID W sold 2,037 shares of common stock on May 6, 2024 at an average price of $405.58 for a total value of $826.17K.Source: Announcement What is statement
Carlisle Companies Insider Sold Shares Worth $826,166, According to a Recent SEC Filing
David W Smith, Vice President, Sustainability, on May 06, 2024, sold 2,037 shares in Carlisle Companies (CSL) for $826,166. Following the Form 4 filing with the SEC, Smith has control over a total of
Form 144 | Carlisle Companies(CSL.US) Officer Proposes to Sell 435.81K in Common Stocks
SEC FILLINGS DISCLOSED/ May 3, $Carlisle Companies(CSL.US)$ Officer Stephen P Aldrich intends to sell 1,095 shares of its common stock on May 3, with a total market value of approximately $435.81K.
ITT Q1 Earnings & Revenues Beat Estimates, Increase Y/Y
Comments
The share price has tracked EPS growth, suggesting market sentiment towards the shares remains steady. The stock's recent performance has improved, with a better one-year total shareholder return than the five-year return. Dividends have enhanced the total shareholder return.
Those Who Invested in Carlisle Companies (NYSE:CSL) Five Years Ago Are up 202%CSL anticipates robust annualized double-digit earnings growth over the medium term, driven by strong patient demand for its immunoglobulins franchise. The company has bounced back from the pandemic's impact on its blood plasma collections.
The positive trends in Carlisle Companies' ROCE and its ability to consistently reinvest in itself make it an attractive investment. Investors are expecting more growth in the future. However, it's important to check if these trends will continue.
The stock is seen as overpriced by valuation models, making it less attractive for purchase. With the company's low likelihood of significant earnings growth, its investment appeal is diminished. Profits could be made if share prices meet realistic values.
Carlisle Companies' growth is praised, but future performance remains key. Dividends have boosted total shareholder return, despite short-term performance being below market. Effective business strategy is expected to continue but investors should note identified risks.
1
Read more